I know they sound similar but throbocytemia/thrombocytosis is too much platelets. and thromobocytopenia is too little.

fortunately, in hematology, gentetic testing is not considered "out of space" medicine, and is pretty much the norm. not only for diagnosis, but also for stratification of patients according to risk groups.

I hope your tests come back normal, and that you have significant improvment of both the ILD and the MG, upon ceasation of the medication. we don't really know if it could have been brought about by agrylin as well.

it is a relatively new drug, and you may be the first to have this adverse side effect. we know that many medications can lead to immune dysregulation and secondary autoimmune disease (many which fortunately reverse upon ceasation of the offending agent), this is relatively rare, so may be missed in clinical trials, so how can we know for sure that agrylin does not?


alice